July 23, 2014

Inergetics, a developer of nutritional supplements, announced that the company will be presenting Martha Stewart Essentials, a line of whole food-based vitamin supplements developed in tandem with Martha Stewart herself at Cardinal Health's Retail Business Conference.

July 23, 2014

Mylan on Wednesday announced that U.S. District Court for the district of New Jersey granted a temporary restraining order against Apotex Inc. and Apotex Corp. relating to Paroxetine CR.

July 23, 2014

The first batch of vaccines for the upcoming flu season is on its way to pharmacies, hospitals and doctors offices.

July 23, 2014

The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.

July 22, 2014

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.

July 22, 2014

The Little Clinic announced a number of new store openings, including its first clinic locations in Virginia.

July 22, 2014

Walgreens on Tuesday announced the new Balance Rewards for healthy choices initiatives, which is aimed at helping participants modify behavior risk factors associated with the nation's most pressing public health issues.

July 22, 2014

Walgreens announced the official opening of a new pharmacy at Children's National Health System.

July 21, 2014

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.

July 21, 2014

Illinois Gov. Pat Quinn signed a bill Monday that opens up medical marijuana to treat symptoms of epilepsy in adults and children.

July 21, 2014

Innocutis on Monday announced the introduction of Sitavig (acyclovir) 50-mg buccal tablet into North American markets.

July 21, 2014

Commentary published online Monday addresses the controversy surrounding the high costs of new Hepatitis C virus treatments and implications for the growing specialty pharmacy market. 

 

July 21, 2014

The new KL1Plus double counts the tablets it dispenses and can then store the count data for up to 10 years.

July 21, 2014

The Food and Drug Administration’s Center for Drug Evaluation and Research is providing an update to key leadership positions within the Office of Generic Drugs, the agency announced.

July 21, 2014

The annual rate of HIV diagnoses dropped by 33% between 2002 and 2011, according to a research letter in this week’s issue of the Journal of the American Medical Association.

July 21, 2014

Sandoz on Monday announced an agreement with Anacor Pharmaceuticals to obtain exclusive rights to commercialize Kerydin (tavaborole) topical solution, 5%, through its branded dermatology business, PharmaDerm.

July 21, 2014

Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.

July 18, 2014

The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.

July 18, 2014

FedEx on Thursday was indicted as a co-conspirator for illegally distributing pharmaceuticals sourced from a pair of rogue online pharmacies.

 

July 18, 2014

According to a recent study published in Pediatrics, use of milliliters as a dosage measurement unit, as opposed to teaspoons and tablespoons, cut down significantly on medication dosing errors when parents administered medicines to their children.

 

July 17, 2014

There is “something brewing in Congress” these days, NACDS president and CEO Steve Anderson wrote in a July 16 newsletter to NACDS chain members.

July 17, 2014

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

July 17, 2014

Mylan on Thursday announced that the U.S. District Court for the district of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to paroxetine CR, the generic version of GSK's Paxil CR.

July 17, 2014

Millennials are proactively carving out their futures and making some very distinct life choices, which includes keeping an eye on health and wellness, according to new research by the Hartman Group.